ISDS Case Map
intellectual property
Consumers' Association of Penang submitted a Memorandum on June 2025 to strongly urge the Malaysian government not to rush to endorse and/or sign the trade deal with EFTA. If a deal is to be signed, such a deal must not contain any TRIPS-plus obligation.
The proposed Malaysia-EFTA Economic Partnership Agreement (MEEPA) could negatively affect public health, farmers' rights, and food security in Malaysia. It includes "TRIPS-plus" intellectual property provisions that extend patent monopolies, limit access to affordable generic medicines, and increase drug costs.
Malaysian negotiators have accepted intellectual property protections above those required by the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights, which will adversely affect affordable and equitable access to medicines in Malaysia for generations.
India and the European Union are likely to agree upon a comprehensive free trade agreement instead of an interim deal, an official said.
India safeguards its $25B generic drug industry by excluding data exclusivity from the UK FTA, ensuring affordable drug access and faster generic launches.
On January 14 this year, President William Ruto and His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the United Arab Emirates (UAE), signed a Comprehensive Economic Partnership Agreement (CEPA) between their respective countries.
International investment laws focus mostly on the rights of the investor and diverse opinions of generally accepted international principles such as fair and equitable treatment that encourage investors to litigate intellectual property through Investor State Dispute Settlement
Trump's trade war has only just begun and while Australia has been right to steer clear of retaliation, it may deliver some scope in abandoning the worst aspects of our free trade agreements.
While the Thailand - EFTA agreemnts avoids TRIPS-plus measures that would directly impact medicine access and the universal healthcare system, Thai CSOs group remain concerns regarding border measures and intellectual property enforcement.
